How Do I Get My Child Evaluated for Autism?

Your first step is to bring your concerns to your child’s pediatrician, who can perform a standardized screening and, if results warrant it, refer you for a full diagnostic evaluation. The American Academy of Pediatrics recommends that all children be screened specifically for autism at 18 and 24 months of age, with immediate referral when screening suggests an elevated likelihood.¹ In practice, the path from first concern to formal diagnosis involves several stages, and understanding each one helps you advocate more effectively for your child.

Signs That Often Prompt Parents to Seek an Evaluation

Research on infants who later receive an autism diagnosis shows that subtle differences in social interest and communication can appear during the first year of life, well before most parents or clinicians suspect anything specific. By the second year, those differences tend to become more apparent. A child might not respond to their name consistently, show limited use of gestures like pointing or waving, avoid eye contact, or seem uninterested in social games like peek-a-boo.² Repetitive behaviors, intense focus on specific objects, and unusual sensory reactions (like strong aversion to certain textures or sounds) are also common early features.

One prospective study found that while children later diagnosed with autism differed from typically developing peers on most social communication measures by 12 months, the clearest early distinguishing marker at that age was a lower use of communicative gestures.³ Not every child who shows a delay in one of these areas will turn out to have autism, and not every autistic child will show all of these signs. But if you are noticing a cluster of social and communication differences, that is a reasonable basis for asking your pediatrician about screening.

What Happens at the Pediatrician’s Office

At well-child visits, most pediatricians use the Modified Checklist for Autism in Toddlers (M-CHAT), a short parent-completed questionnaire designed to flag children who should be evaluated further. A meta-analysis of studies on the M-CHAT found pooled sensitivity of about 83% and specificity of about 94%, meaning it catches most children who do have autism and correctly clears most who do not.⁴ The follow-up interview portion of the M-CHAT, where the clinician asks you more detailed questions about any flagged items, improves accuracy considerably.

A separate meta-analysis looking specifically at high-risk children (those already referred for developmental concerns) found that the M-CHAT’s positive predictive value was moderate in that group but quite low in general-population screening, reinforcing the idea that a positive M-CHAT result should always be followed by a more thorough evaluation rather than treated as a diagnosis.⁵ In other words, the screener is meant to open a door, not close the conversation.

One frustration many parents encounter is that a positive screening does not always lead to a prompt referral. In studies without any intervention to improve referral practices, pediatricians referred children to evaluation and early intervention services at rates ranging from only 20% to about 58%.⁶ Another study found that only about 31% of children were referred to a specialist for additional evaluation after screening.⁷ Barriers include the provider’s confidence in the screening tool, limited local specialists, and sometimes a “wait and see” approach that delays the process. If your pediatrician suggests waiting without a clear reason, you are within your rights to request a referral directly.

The Formal Diagnostic Evaluation

A diagnostic evaluation is more thorough than a screening and is typically conducted by a developmental pediatrician, child psychologist, child psychiatrist, or a multidisciplinary team that may include speech-language pathologists and occupational therapists. The current gold standard involves qualified professionals assessing behavioral observations, developmental history, and parent-report information together.⁸ This process is time-consuming by design, because autism is a behavioral diagnosis with no blood test or brain scan to confirm it.

Clinicians commonly use two structured instruments during an evaluation. The Autism Diagnostic Observation Schedule (ADOS-2) is an interactive assessment where the clinician engages the child in activities designed to elicit social and communicative behaviors. Meta-analyses report that the ADOS-2 has sensitivity between roughly 87% and 92% and specificity between about 75% and 85%, making it a strong but imperfect tool.⁹ The Autism Diagnostic Interview-Revised (ADI-R) is a detailed parent interview that covers the child’s developmental history. Its accuracy is somewhat lower than the ADOS-2, with sensitivity around 75% and specificity around 82%, and it performs better in research settings than in clinical ones.⁹

Neither instrument alone is considered sufficient. A skilled clinician uses them alongside their own clinical judgment, cognitive testing, language assessment, and a review of school or daycare reports. The evaluation may also include ruling out other conditions that can look like autism or that frequently occur alongside it, such as ADHD, anxiety disorders, language disorders, and intellectual disability.¹⁰ Getting this differential picture right matters because the right supports depend on whether the features you are seeing are autism alone, another condition, or both.

Medical and Genetic Testing

In addition to the behavioral evaluation, some clinicians recommend a basic medical workup to check for underlying conditions that can be associated with autism. This may include a hearing test (since hearing loss can mimic social communication delays), and in some cases, metabolic screening through bloodwork and urine tests.¹¹ Genetic testing, particularly chromosomal microarray analysis, is increasingly offered to families seeking to identify a genetic basis. While no single gene accounts for most autism, identifying a genetic variant can sometimes explain associated medical features and help guide long-term health monitoring. Genetic testing is optional and does not change the behavioral diagnosis itself.

School-Based Evaluation Versus Medical Diagnosis

Parents in the United States often learn that there are two separate evaluation systems for autism, and the difference between them causes real confusion. A medical (or clinical) diagnosis is made by a licensed healthcare provider using standardized diagnostic criteria. A school-based determination is made by a school team to decide whether a child qualifies for special education services under the Individuals with Disabilities Education Act (IDEA).

These two systems do not always agree. In many states, a clinical diagnosis of autism is not required for a child to receive special education services under an autism classification. Conversely, a clinical diagnosis does not automatically qualify a child for school services. Eligibility in the school system hinges on whether the condition affects the child’s educational performance.¹² Identification practices also vary from state to state, with most states drawing at least partly on federal guidelines but applying them with different levels of specificity.¹³

Research comparing the two systems has found that children identified as autistic only through their school (without a medical diagnosis) tended to have less severe clinician-rated autism symptoms than those with a medical diagnosis.¹⁴ And the educational classification alone did not differentiate well between students with and without autism on measures of language, social competence, and academics, while the ADOS-2 did.¹⁵ The practical takeaway: if you want a definitive diagnosis that will be recognized by healthcare providers, insurers, and across state lines, pursue a medical evaluation. If your immediate goal is getting your child classroom supports while you wait for a clinical appointment, a school-based evaluation can start that process.

You can request a school evaluation at any time by writing a letter to your school district. The district is legally required to respond, usually within a set number of days depending on your state. This is separate from the medical path and can run in parallel.

Dealing with Wait Times

One of the most stressful parts of this process is the wait. Multiple factors create a diagnostic bottleneck: evaluations take considerable time, there are not enough specialists, and the cost of care can limit options.¹⁶ In many areas of the United States, wait times for a developmental pediatrician are six months to over a year. Some families report waiting two years.

Several strategies can help shorten the wait or make productive use of the time:

Get on multiple lists: Call every developmental pediatrician, child psychologist, and autism clinic within a reasonable distance and put your child on each waitlist. Cancellations happen, and being on several lists increases your chance of an earlier slot.
Request early intervention now: In the United States, children under three are eligible for Part C Early Intervention services through IDEA regardless of whether they have a diagnosis. You can self-refer by calling your state’s early intervention program. A formal autism diagnosis is not required to receive speech therapy, occupational therapy, or developmental support through this program.
Ask about triage models: Some clinics now use fast-track triage systems where less complex cases are evaluated by community-based specialists rather than the full multidisciplinary team, reducing wait times without sacrificing diagnostic accuracy.¹⁷
Document everything: While you wait, keep a log of specific behaviors you observe, including short video clips when possible. Note social interactions, communication attempts, repetitive behaviors, and sensory responses. This documentation is genuinely useful to the evaluating clinician and can make the appointment more efficient.

Telehealth Evaluation as an Option

Telehealth-based autism assessments expanded rapidly during the pandemic and have continued to develop since. A scoping review found that telehealth methods for diagnosing autism were between 80% and 91% accurate compared with traditional in-person diagnosis.¹⁸ One tool designed specifically for toddlers, the TELE-ASD-PEDS, showed diagnostic agreement with in-person evaluation in 94% of cases, and the vast majority of caregivers reported satisfaction with the experience.¹⁹

Telehealth will not replace a comprehensive in-person evaluation in all cases. Children whose presentation is subtle or who have complex co-occurring conditions may still need hands-on assessment. But for younger children with more clear-cut presentations, a telehealth evaluation can provide a reliable diagnosis faster than waiting months for an in-person appointment. Ask your referring provider whether any telehealth-capable clinics serve your area.

Why Early Evaluation Matters

A reliable autism diagnosis is possible by age two, and by age three the diagnosis tends to be stable.² Children diagnosed before age three access more intervention hours and tend to show better verbal and overall cognitive outcomes at school age than those diagnosed later. They are also more likely to attend mainstream schools and require less ongoing support.²⁰ It is worth noting that the research on which specific early intervention programs produce the best long-term outcomes is still developing. Some evidence supports Early Intensive Behavioral Intervention in particular, but even beyond any single program, an early diagnosis allows families and schools to create an environment that works better for the child.²¹

Despite these findings, only about half of children evaluated for possible autism had actually received Part C Early Intervention services, and Black families had lower odds of accessing those services than White families.²² This points to a broader pattern of access disparities worth understanding.

Disparities in Who Gets Evaluated and When

Autism affects children of all racial, ethnic, and socioeconomic backgrounds, but the pathway to diagnosis is not equally smooth for everyone. Recent surveillance data show that autism prevalence among Black, Hispanic, and Asian or Pacific Islander children has converged with or even exceeded prevalence among White children in some cohorts, which reflects expanded screening efforts rather than any real change in who develops autism.²³ A large study tracking diagnosis rates from 2017 to 2021 found that by the end of the study period, the median age at diagnosis across racial and ethnic groups clustered between about 4.4 and 5 years, with gaps narrowing over time.²⁴

But convergence in raw prevalence numbers does not mean equity. Disparities persist in the severity at the time of diagnosis (children from underserved communities are more likely to have co-occurring intellectual disability by the time they are identified), in the intensity of services received, and in long-term outcomes.²³ Families who speak a language other than English may also face screening tools that were not designed for their cultural context. Research shows that translating a screening tool into another language is not enough; the concepts themselves sometimes need adaptation to be valid in a different cultural setting.²⁵

Girls and the Problem of Camouflaging

Another group that tends to be underidentified is girls. Autism is diagnosed roughly three to four times more often in boys, but a growing body of research suggests that part of this gap reflects missed diagnoses rather than a true difference in prevalence. Evidence points to a “female autism phenotype” in which girls and women express autism in ways that do not fit traditional diagnostic expectations. They may have more socially oriented interests, maintain superficial conversational skills, and actively camouflage their difficulties by mimicking peers’ social behavior.²⁶

Women diagnosed in late adolescence or adulthood have described years of “pretending to be normal” and reported that their gender specifically led professionals to overlook the possibility of autism.²⁷ If you are concerned about a daughter who seems to struggle socially despite appearing to cope on the surface, it is worth raising those concerns explicitly with the evaluating clinician and asking whether they have experience identifying autism in girls. Clinicians who rely heavily on the ADOS-2 should be aware that the instrument’s diagnostic performance can differ for females, with lowered scores and weaker correlation with parent-report measures in some research.²⁸

Insurance and Cost

The cost of a private autism evaluation varies widely depending on your location and the type of provider, but it can range from several hundred to several thousand dollars. Most private insurance plans are now required to cover autism screening, diagnosis, and treatment, though the specific coverage levels vary by state. All 50 states have adopted some form of autism insurance mandate, but differences exist in what services are included and at what level, with allied health services like occupational therapy covered inconsistently.²⁹

If you have Medicaid or the Children’s Health Insurance Program (CHIP), diagnostic evaluations are generally covered. Children under three can also access federally funded Part C Early Intervention services at no cost to the family regardless of insurance status. If your child is over three and enrolled in public school, the school district is required to evaluate at no cost to you if there is a suspected disability affecting educational performance.

Preparing for the Evaluation Appointment

When you do get an appointment, arriving prepared makes a real difference. Bring any previous developmental screening results, school reports, therapy notes, and your own behavioral log. Short video clips showing the specific behaviors that concern you are especially valuable because children do not always display their full range of behavior in a clinical setting. Think about your child’s development across several areas: how they communicate, how they play (alone and with others), how they respond to changes in routine, and whether they have any unusual sensory preferences or aversions.

Families in the United Kingdom have reported that the assessment process feels overwhelming and that support across the whole diagnostic journey is often lacking despite being recognized as important by both families and clinicians.³⁰ This is a common experience internationally. You do not need to navigate it alone. Parent advocacy organizations, local autism societies, and online communities can connect you with other families who have been through the process in your specific area and can share practical advice about which providers accept your insurance, which clinics have shorter waits, and what to expect during the evaluation itself.

When the Evaluation Does Not Yield a Clear Diagnosis

Sometimes the evaluation concludes without a definitive autism diagnosis. This does not necessarily mean your concerns were unfounded. A child might not yet be old enough for certain features to be clearly distinguishable from typical variation, or their profile might overlap with another condition like social communication disorder, ADHD, or anxiety. One study looking at a clinical sample of over 1,200 individuals found substantial overlap between those being evaluated for autism and those ultimately diagnosed with ADHD, anxiety-related disorders, and conduct disorder.³¹ In these cases, the evaluator should explain what they did observe, what alternative diagnoses they considered, and whether re-evaluation at a later age would be appropriate. If your child is receiving early intervention services, those can and should continue even without a formal diagnosis as long as developmental concerns remain.

1
Pediatrics. Primary Care Pediatricians’ Referral Decisions for Autism in Early Childhood: A Systematic Review
2
PubMed Central. Early Identification of Autism: Early Characteristics, Onset of Symptoms, and Diagnostic Stability
3
PubMed. Early indicators of autism spectrum disorders at 12 and 24 months of age: a prospective, longitudinal comparative study
4
PubMed Central. Sensitivity and Specificity of the Modified Checklist for Autism in Toddlers (Original and Revised): A Systematic Review and Meta-analysis
5
PubMed. Assessing the accuracy of the Modified Checklist for Autism in Toddlers: a systematic review and meta-analysis
6
PubMed. Primary Care Pediatricians’ Referral Decisions for Autism in Early Childhood: A Systematic Review
7
Pediatrics. Screening and Referral Practices for Autism Spectrum Disorder in Primary Pediatric Care
8
PubMed. Diagnostic procedures in autism spectrum disorders: a systematic literature review
9
PubMed. Systematic Review and Meta-Analysis of the Clinical Utility of the ADOS-2 and the ADI-R in Diagnosing Autism Spectrum Disorders in Children
10
PubMed Central. Differential Diagnosis of Autism and Other Neurodevelopmental Disorders
11
Genetics in Medicine. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions
12
Psychology in the Schools. From eligibility assessment to intervention for students with autism spectrum disorder
13
PubMed. An Analysis of State Autism Educational Assessment Practices and Requirements
14
Focus on Autism and Other Developmental Disabilities. Comparing Autism Symptom Severity Between Children With a Medical Autism Diagnosis and an Autism Special Education Eligibility
15
PubMed. Educational and Diagnostic Classification of Autism Spectrum Disorder and Associated Characteristics
16
PubMed Central. Whittling Down the Wait Time: Exploring Models to Minimize the Delay from Initial Concern to Diagnosis and Treatment of Autism Spectrum Disorder
17
PubMed. Reducing Time to Diagnosis of Autism Spectrum Disorder Using an Integrated Community Specialty Care Model: A Retrospective Study
18
PubMed Central. A scoping review of telehealth diagnosis of autism spectrum disorder
19
PubMed Central. In-home Tele-assessment for Autism in Toddlers: Validity, Reliability, and Caregiver Satisfaction with the TELE-ASD-PEDS
20
PubMed. School Age Outcomes of Children Diagnosed Early and Later with Autism Spectrum Disorder
21
PubMed Central. Early diagnosis of autism and impact on prognosis: a narrative review
22
PubMed Central. Access to Part C, Early Intervention for children younger than 4 years evaluated for autism spectrum disorder
23
PLOS Mental Health. Understanding disparities in autism diagnosis and care: A socioecological perspective
24
JAMA Network Open. Racial and Ethnic Differences in Rates and Age of Diagnosis of Autism Spectrum Disorder
25
PubMed Central. Screening tools for autism in culturally and linguistically diverse paediatric populations: a systematic review
26
Review Journal of Autism and Developmental Disorders. The Female Autism Phenotype and Camouflaging: a Narrative Review
27
PubMed Central. The Experiences of Late-diagnosed Women with Autism Spectrum Conditions: An Investigation of the Female Autism Phenotype
28
PubMed. ADOS-2 Module 4: Psychometric Properties and Diagnostic Performance at an Autism-specialized Clinic
29
PubMed Central. Analyzing State Autism Private Insurance Mandates for Allied Health Services: A Pilot Study
30
PubMed Central. How can we improve the timeliness and quality of diagnostic assessment for children with possible autism?
31
PubMed. Using machine learning to improve diagnostic assessment of ASD in the light of specific differential and co-occurring diagnoses